Motley Fool Hidden Gems Investing

Motley Fool Hidden Gems Investing

Motley Fool Hidden Gems Investing is a daily podcast for stock investors. Weekday episodes offer a long-term perspective on business news with The Motley Fool's investment analysts. Weekend shows are a mix of personal finance and longer-form interviews.
00:00
00:00

Rezumatul episodului

Two or three day-long sessions a year. Relief from depression symptoms that lasts up to twelve months. A 40% response rate in patients who’ve failed every treatment they’ve tried for the past three to four years. Motley Fool host Sanmeet Deo talks with Kabir Nath, CEO of Compass Pathways — the publicly traded biotech company pioneering psilocybin therapy for treatment-resistant depression and PTSD — about what their phase three clinical data actually shows, how you build a sustainable business when your best case outcome is a patient who barely needs your drug, and why this could be psychiatry’s immuno-oncology moment. Compass Pathways is listed on NASDAQ under the ticker CMPS. Host: Sanmeet Deo Guest: Kabir Nath, CEO of Compass Pathways Producers: Bart Shannon, Lauren Budabin Advertisements are sponsored content and provided for informational purposes only. The Motley Fool and its affiliates (collectively, “TMF”) do not endorse, recommend, or verify the accuracy or completeness of the statements made within…

Episoade

2426-

The FDA Is About to Rule on Psilocybin Therapy — Here’s What Investors Need to Know

Two or three day-long sessions a year. Relief from depression symptoms that lasts up to twelve months. A 40% response rate in patients who’ve failed every treatment they’ve tried for the past three to four years. Motley Fool host Sanmeet Deo talks with Kabir Nath, CEO of Compass Pathways — the publicly traded biotech company pioneering psilocybin therapy for treatment-resistant depression and PTSD — about what their phase three clinical data actually shows, how you build a sustainable business when your best case outcome is a patient who barely needs your drug, and why this could be psychiatry’s immuno-oncology moment. Compass Pathways is listed on NASDAQ under the ticker CMPS. Host: Sanmeet Deo Guest: Kabir Nath, CEO of Compass Pathways Producers: Bart Shannon, Lauren Budabin Advertisements are sponsored content and provided for informational purposes only. The Motley Fool and its affiliates (collectively, “TMF”) do not endorse, recommend, or verify the accuracy or completeness of the statements made within…

22 nov. 2026
2425-

Is a Japan-Style Downturn Possible in the U.S.?

The Japanese stock market crashed in 1990 and didn’t exceed its previous peak until 2024. Host Robert Brokamp answers a Fool’s question about whether such a long-term bear market could happen in the U.S. Topics discussed:-The history of Japan’s financial asset bubble, which put most other bubbles to shame-The valuation of the U.S. stock market, and what happened the last time stocks were this pricey-Strategies for surviving a longer-term downturn-How the portfolio of someone who retired in 2000 has fared after retiring at the beginning of the worst stretch for U.S. stocks of modern times Host: Robert Brokamp, CFP®, EAEngineer: Bart Shannon Learn more about your ad choices. Visit megaphone.fm/adchoices

21 nov. 2026
2424-

Anthropic’s IPO Hangover, Nvidia’s Future Without Jensen, and the Worst Acquisitions Ever

Anthropic’s blockbuster IPO has barely begun trading, but investors are already questioning whether its trillion-dollar valuation can hold up. Travis Hoium, Lou Whiteman, and Jason Moser discuss Nvidia’s leadership transition, growing concerns about AI chip sales to China, and some of the most disastrous acquisitions in corporate history. They also examine the latest consumer earnings and highlight two stocks on their radar. Travis Hoium, Lou Whiteman, and Jason Moser discuss: - Anthropic’s IPO Volatility - Nvidia’s Leadership Transition - China Chip Export Risks - Worst Corporate Acquisitions - Consumer Earnings Check - Stocks on Radar Companies discussed: Anthropic (ANT), Nvidia (NVDA), SpaceX (SPCX), Alphabet (GOOGL), Meta Platforms (META), Microsoft (MSFT), Apple (AAPL), RH (RH), Texas Instruments (TXN), Advanced Micro Devices (AMD), Intuit (INTU), Bending Spoons (BSP), Netflix (NFLX), Verizon (VZ), Alibaba (BABA), Apollo Global Management (APO), Teladoc Health (TDOC), News Corp (NWSA), Mattel (MAT),…

20 nov. 2026
2423-

Anthropic Gets a Blockbuster IPO, Take Two Gets a Blockbuster GTA VI Release, EVERYBODY GETS A BLOCKBUSTER!!!

It’s official: Anthropic’s IPO was a resounding success. What was initially targeted to be an $80 billion raise ended up being a $100 billion capital raise, the largest in history (so far). Matt, Jon, and Tyler discuss the monumental IPO and the ripple effects. Plus, Take Two’s release of Grand Theft Auto VI was the largest game launch ever and a mailbag about the effects of the Anthropic IPO on the rest of the market Have a question? Email us; podcasts@fool.com Tyler Crowe, Jon Quast and Matt Frankel discuss:- Anthropic’s record IPO- What do you do with $100 billion, anyways?- What is a PBC- Can GTA VI lead to another golden age for $TTWO’s stock?- Mailbag Companies discussed: ANT, SPCX, PATH, TTWO, AVGO, GOOG, MSFT Host: Tyler CroweGuests: Matt Frankel, Jon QuastEngineer: Bart Shannon Disclosure: Advertisements are sponsored content and provided for informational purposes only. The Motley Fool and its affiliates (collectively, “TMF”) do not endorse, recommend, or verify the accuracy or completeness of the…

19 nov. 2026
2422-

Can Nvidia Thrive Without Jensen Huang?

Nvidia delivers blockbuster earnings under interim CEO Colette Kress, but investors still have questions about its future without Jensen Huang. Target’s turnaround is gaining momentum as shoppers respond to lower prices, while Waymo faces new regulatory setbacks in California. What do these developments mean for investors navigating AI, consumer spending, and autonomous driving? Travis Hoium, Lou Whiteman, and Rachel Warren discuss: - Nvidia’s Leadership Takes the Stage - Nvidia’s Earnings Impress - Target’s Turnaround Momentum - Consumer Spending Trends - Waymo’s California Freeway Ban - Autonomous Driving Timeline Companies discussed: Nvidia (NVDA), Texas Instruments (TXN), Target (TGT), Nike (NKE), Lululemon Athletica (LULU), Walmart (WMT), TJX Companies (TJX), General Mills (GIS), PepsiCo (PEP), Coca-Cola (KO), Alphabet (GOOGL), Tesla (TSLA), Uber Technologies (UBER) Host: Travis Hoium Guests: Lou Whiteman, Rachel Warren Engineer: Dan Boyd Disclosure: Advertisements are sponsored content and provided for…

18 nov. 2026